Stock listing
Werewolf Therapeutics, Inc.
Selected listing: HOWL · NASDAQ · USD · US
Werewolf Therapeutics, Inc. (NASDAQ:HOWL), Health Technology. Latest release Jul 31, 2026: Werewolf Therapeutics Reports Second Quarter 2026 Financial Results…
- Ticker
- NASDAQ:HOWL
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Werewolf Therapeutics, Inc.
Werewolf Therapeutics, Inc. is a public company listed under the ticker HOWL, operating in the American market. Focused on innovative therapeutic solutions, Werewolf Therapeutics aims to advance its development in the biotechnology sector.
Latest news from Werewolf Therapeutics, Inc.
Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates
July 31, 2026
Werewolf Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Updates
May 7, 2026
Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates
March 26, 2026
Werewolf Therapeutics Announces Plan to Explore Strategic Alternatives
February 24, 2026
Werewolf Therapeutics Announces Pipeline and Business Updates
December 18, 2025
Research Werewolf Therapeutics, Inc.
Werewolf Therapeutics, Inc. company profile
View the public company page for Werewolf Therapeutics, Inc. on 6ix.
Werewolf Therapeutics, Inc. news
Read company news and market updates connected to Werewolf Therapeutics, Inc..
Werewolf Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Werewolf Therapeutics, Inc..